Diabetes Care 30:1143-1149, 2007 DOI: 10.2337/dc06-1809 © 2007 by the American Diabetes Association
Whole-Body Glycolysis Measured by the Deuterated-Glucose Disposal Test Correlates Highly With Insulin Resistance In Vivo
1 KineMed, Inc., Emeryville, California Address correspondence and reprint requests to Marc Hellerstein, MD, PhD, Nutritional Sciences and Toxicology, 309 Morgan Hall, University of California at Berkeley, Berkeley, CA 94720. E-mail: march{at}nature.berkeley.edu OBJECTIVEThe purpose of this study was to compare an in vivo test of whole-body glycolysis, the deuterated-glucose disposal test (2H-GDT), with insulin sensitivity measured by the euglycemic-hyperinsulinemic glucose clamp and the steady-state plasma glucose (SSPG) test. RESEARCH DESIGN AND METHODSThe 2H-GDT consists of an oral glucose challenge containing deuterated glucose, followed by measurement of heavy water (2H2O) production, which represents whole-body glycolytic disposal of the glucose load. 2H2O production is corrected for ambient insulin concentration as an index of tissue insulin sensitivity. The 2H-GDT was compared with euglycemic-hyperinsulinemic glucose clamps in healthy lean subjects (n = 8) and subjects with the metabolic syndrome (n = 9) and with the SSPG test in overweight (n = 12) and obese (n = 6) subjects. RESULTSA strong correlation with the clamp was observed for the 75-g and 30-g 2H-GDT (r = 0.95, P < 0.0001 and r = 0.88, P < 0.0001, respectively). The 2H-GDT and clamp studies revealed marked insulin resistance in subjects with metabolic syndrome compared with lean control subjects. The correlation with the clamp was maintained in each group (lean, r = 0.86, P < 0.01; metabolic syndrome, r = 0.81, P < 0.01) for the 75-g test. The 2H-GDT also correlated strongly with the SSPG test (r = 0.87, P < 0.0001) in overweight and obese subjects. CONCLUSIONSThe 2H-GDT, which measures whole-body glycolysis in humans in a quantitative manner, correlates highly with the euglycemic-hyperinsulinemic glucose clamp and the SSPG test. Impaired insulin-mediated whole-body glycolysis is a feature of insulin resistance, which provides a means of assessing insulin sensitivity in vivo.
Abbreviations: AUC, area under the curve EGP, endogenous glucose production 2H-GDT, deuterated-glucose disposal test HOMA, homeostasis model assessment IR-MS, isotope ratio-mass spectrometry QUICKI, quantitative insulin sensitivity check index SSPG, steady-state plasma glucose TBW, total body water
This article has been cited by other articles:
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||